For patients living with severe depression that has not responded to multiple rounds of traditional antidepressant medication, few experiences are more discouraging than continuing to feel unwell despite trying treatment after treatment. In recent years, ketamine therapy has emerged as one of the most significant advances in psychiatric medicine for exactly this population — offering rapid, meaningful relief for patients with treatment-resistant depression and, in some cases, acute suicidal ideation. For patients across the city exploring this option, Dr. Uday Kiran, CEO of Bharosa Neuro Psychiatry Hospitals, provides carefully supervised Ketamine Therapy in Hyderabad as part of a comprehensive, evidence-based approach to severe mood disorders.
What Is Ketamine Therapy?
Ketamine has been used safely in medical settings for decades, originally as an anesthetic agent. Over the past several years, research has revealed that at carefully controlled, low doses, ketamine can produce rapid and significant antidepressant effects — often within hours to days, compared to the several weeks typically required for traditional antidepressant medications to take effect. This rapid onset of action has made ketamine therapy a genuinely important development for patients facing severe depressive episodes, particularly when a faster response is clinically necessary.
Unlike standard antidepressants, which primarily target serotonin and other monoamine neurotransmitters, ketamine works through a different mechanism involving the brain's glutamate system, believed to help rapidly restore healthy communication between brain cells and promote the growth of new neural connections. This distinct mechanism is part of why Ketamine Therapy in Hyderabad can be effective even for patients who have not responded to multiple traditional medications targeting different neurotransmitter pathways.
Who May Benefit From Ketamine Therapy?
Ketamine therapy is generally reserved for patients with specific, more severe clinical presentations, rather than being used as a first-line treatment for mild or moderate depression. Common candidates for Ketamine Therapy in Hyderabad include:
- Treatment-resistant depression, typically defined as depression that has not adequately improved after trying two or more different classes of antidepressant medication
- Severe depression with acute suicidal ideation, where the rapid onset of ketamine's effects can provide critical, time-sensitive relief while longer-term treatments are established
- Certain cases of bipolar depression, under careful psychiatric supervision given the complexity of managing bipolar disorder
- Patients who have not tolerated or responded to other advanced treatments, such as multiple medication trials or psychotherapy alone
Dr. Uday Kiran and his team conduct a comprehensive psychiatric and medical evaluation before recommending Ketamine Therapy in Hyderabad, ensuring the treatment is appropriate for each patient's specific clinical picture and ruling out any contraindications.
The Treatment Process
Ketamine therapy is typically administered in a carefully monitored clinical setting, often through a series of sessions delivered over several weeks, followed by less frequent maintenance sessions if the treatment proves effective. During each session, patients are closely monitored by trained medical staff, with vital signs tracked throughout the treatment and recovery period.
Because ketamine can cause temporary changes in perception, mild dissociation, or changes in blood pressure during administration, sessions are conducted in a controlled, supervised environment, and patients are monitored until these effects have fully resolved before being discharged. This structured, medically supervised approach is central to how Dr. Uday Kiran's team delivers Ketamine Therapy in Hyderabad safely and responsibly.
Safety and Monitoring
Given ketamine's history as an anesthetic agent and its potential for misuse outside of medical settings, safety and careful monitoring are paramount in any legitimate psychiatric treatment program. At Bharosa Neuro Psychiatry Hospitals, Ketamine Therapy in Hyderabad is administered only within a strictly controlled clinical environment, with thorough pre-treatment screening to assess medical history, current medications, and any risk factors that might affect suitability for treatment.
Throughout each session, trained medical personnel monitor patients closely, and treatment is only continued as part of a broader, psychiatrist-supervised care plan — never as an isolated or unsupervised intervention. This rigorous safety framework reflects Dr. Uday Kiran's broader commitment to responsible, evidence-based psychiatric care.
Ketamine as Part of a Broader Treatment Plan
While ketamine therapy can produce rapid symptom relief, it is most effective and sustainable when integrated into a comprehensive treatment plan rather than used in isolation. At Bharosa, ketamine therapy is typically combined with ongoing psychiatric care, ensuring that the underlying factors contributing to a patient's depression continue to be addressed even as ketamine provides more immediate relief. Continued psychotherapy also helps patients build on the improved emotional stability that ketamine can provide, supporting more durable, long-term recovery.
This integrated approach ensures that Ketamine Therapy in Hyderabad functions as one important tool within a broader recovery strategy, rather than a standalone quick fix disconnected from the patient's overall psychiatric care.
Realistic Expectations for Patients and Families
While ketamine therapy has shown genuinely promising results for many patients with treatment-resistant depression, it is important for patients and families to understand that individual responses vary. Some patients experience significant, rapid improvement, while others may see more modest benefit or require adjustments to their broader treatment plan. Dr. Uday Kiran's team provides honest, realistic guidance throughout the treatment process, helping patients and families understand what to expect and how progress will be monitored over time.
Why Medical Supervision Matters So Much
Given the complexity and potential risks associated with ketamine, it should only ever be administered within a properly regulated, medically supervised psychiatric setting — never through unsupervised or informal sources. This is one of the most important messages Dr. Uday Kiran emphasizes to patients considering Ketamine Therapy in Hyderabad: legitimate, effective treatment requires thorough evaluation, controlled dosing, professional monitoring, and integration into a comprehensive psychiatric care plan.
Accessible, Specialized Care in LB Nagar
Bharosa Neuro Psychiatry Hospitals, a 110-bed, NABH-accredited facility located at Plot No. 114, Mythripuram, Karmanghat, Opposite TKR College, LB Nagar, Hyderabad – 500079, is equipped to provide Ketamine Therapy in Hyderabad within a properly monitored clinical environment, supported by a multidisciplinary team of more than ten board-certified MD psychiatrists experienced in managing complex and treatment-resistant psychiatric conditions.
A Meaningful Option for Severe, Treatment-Resistant Depression
For patients who have exhausted standard treatment options without adequate relief, ketamine therapy represents a genuinely significant advance in psychiatric care — offering the possibility of rapid, meaningful improvement when other approaches have fallen short. Dr. Uday Kiran and the team at Bharosa Neuro Psychiatry Hospitals are committed to providing safe, carefully supervised Ketamine Therapy in Hyderabad as part of a comprehensive, patient-centered approach to recovery.
If you or a loved one has been struggling with severe, treatment-resistant depression, discussing ketamine therapy with a qualified psychiatric team may offer a path toward relief that other treatments have not been able to provide.
Get in Touch
Bharosa Neuro Psychiatry Hospitals
Plot No. 114, Mythripuram, Karmanghat, Opposite TKR College, LB Nagar, Hyderabad – 500079
📞 +91 9505058886

Medically Reviewed & Approved
This article was clinically reviewed and approved by Dr. Uday Kiran.
MBBS · Psychiatrist · Founder & CEO, Bharosa Neuro Psychiatry Hospital, HyderabadLast reviewed July 11, 2026
